Munoz Flor M, Eckert Linda O, Katz Mark A, Lambach Philipp, Ortiz Justin R, Bauwens Jorgen, Bonhoeffer Jan
Departments of Pediatrics and Molecular Virology and Microbiology, Baylor College of Medicine, Houston, TX, USA.
Department of Obstetrics and Gynecology, University of Washington, Seattle, WA, USA.
Vaccine. 2015 Nov 25;33(47):6441-52. doi: 10.1016/j.vaccine.2015.07.112. Epub 2015 Sep 19.
The variability of terms and definitions of Adverse Events Following Immunization (AEFI) represents a missed opportunity for optimal monitoring of safety of immunization in pregnancy. In 2014, the Brighton Collaboration Foundation and the World Health Organization (WHO) collaborated to address this gap.
Two Brighton Collaboration interdisciplinary taskforces were formed. A landscape analysis included: (1) a systematic literature review of adverse event definitions used in vaccine studies during pregnancy; (2) a worldwide stakeholder survey of available terms and definitions; (3) and a series of taskforce meetings. Based on available evidence, taskforces proposed key terms and concept definitions to be refined, prioritized, and endorsed by a global expert consultation convened by WHO in Geneva, Switzerland in July 2014.
Using pre-specified criteria, 45 maternal and 62 fetal/neonatal events were prioritized, and key terms and concept definitions were endorsed. In addition recommendations to further improve safety monitoring of immunization in pregnancy programs were specified. This includes elaboration of disease concepts into standardized case definitions with sufficient applicability and positive predictive value to be of use for monitoring the safety of immunization in pregnancy globally, as well as the development of guidance, tools, and datasets in support of a globally concerted approach.
There is a need to improve the safety monitoring of immunization in pregnancy programs. A consensus list of terms and concept definitions of key events for monitoring immunization in pregnancy is available. Immediate actions to further strengthen monitoring of immunization in pregnancy programs are identified and recommended.
免疫接种后不良事件(AEFI)的术语和定义存在差异,这为优化孕期免疫接种安全性监测提供了一个错失的机会。2014年,布莱顿协作基金会与世界卫生组织(WHO)合作以填补这一空白。
成立了两个布莱顿协作跨学科特别工作组。一项现状分析包括:(1)对孕期疫苗研究中使用的不良事件定义进行系统的文献综述;(2)对全球范围内利益相关者关于现有术语和定义的调查;(3)以及一系列特别工作组会议。基于现有证据,特别工作组提出了关键术语和概念定义,供2014年7月在瑞士日内瓦由WHO召集的全球专家协商会议进行完善、排序和认可。
使用预先设定的标准,对45项母体事件和62项胎儿/新生儿事件进行了排序,并认可了关键术语和概念定义。此外,还明确了进一步改善孕期免疫接种安全性监测的建议。这包括将疾病概念细化为标准化病例定义,使其具有足够的适用性和阳性预测价值,以便用于全球范围内监测孕期免疫接种的安全性,以及开发指导意见、工具和数据集,以支持全球协调一致的方法。
有必要改善孕期免疫接种的安全性监测。现有一份用于监测孕期免疫接种关键事件的术语和概念定义的共识清单。确定并建议立即采取行动,进一步加强孕期免疫接种项目的监测。